Premium
A derivative of staurosporine (CGP 41:251) shows selectivity for PKC inhibition and in vitro antiproliferative effects as well as in vivo antitumor activity. Int. J. Cancer, 43, 851–866 (1989)
Author(s) -
Meyer T.,
Regenass U.,
Fabbro D.,
Alteri E.,
Rösel J.,
Müller M.,
Caravatti G.,
Matter A.
Publication year - 1999
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/(sici)1097-0215(19990517)81:4<669::aid-ijc26>3.0.co;2-f
Subject(s) - staurosporine , in vivo , regret , protein kinase c , in vitro , int , ex vivo , pharmacology , cancer research , biology , chemistry , kinase , biochemistry , genetics , computer science , machine learning , operating system